TELA Bio (TELA) Free Cash Flow (2018 - 2026)
TELA Bio (TELA) posted quarterly Free Cash Flow of -$11.3 million for Q1 2026, down 15.7% year-over-year from -$13.4 million in Q1 2025, and down 127.55% quarter-over-quarter from -$5.0 million in Q4 2025.
TELA Bio (TELA) Free Cash Flow (2018 - 2026) Analysis & Trends
TELA Bio's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$11.3 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 15.7% year-over-year to -$11.3 million; the TTM figure through Mar 2026 stood at -$30.2 million (up 20.07% YoY), while the FY2025 annual figure was -$28.7 million, up 32.68% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$11.3 million, down from -$5.0 million in the prior quarter.
- The five-year high for Free Cash Flow was -$5.0 million in Q4 2025, with the low at -$14.6 million in Q1 2024.
- The 5-year median for Free Cash Flow is -$10.2 million (2022), against an average of -$9.7 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 103.33% in 2022, then jumped 40.55% in 2025.
- TELA Bio's Free Cash Flow stood at -$10.2 million in 2022, then decreased by 5.9% to -$10.8 million in 2023, then advanced by 22.47% to -$8.3 million in 2024, then surged by 40.55% to -$5.0 million in 2025, then plunged by 127.55% to -$11.3 million in 2026.
- Business Quant data shows TELA's Free Cash Flow at -$11.3 million in Q1 2026, -$5.0 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 279.60 Mn |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn | -9.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.44 Mn |
| Jun 30, 2026 | -9.44 Mn |
| Mar 31, 2026 | -11.29 Mn |
| Mar 31, 2026 | -11.29 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Sep 30, 2025 | -5.93 Mn |
| Sep 30, 2025 | -5.93 Mn |
| Jun 30, 2025 | -8.02 Mn |
| Jun 30, 2025 | -8.02 Mn |
| Mar 31, 2025 | -9.76 Mn |
| Mar 31, 2025 | -9.76 Mn |
| Dec 31, 2024 | -8.35 Mn |
| Dec 31, 2024 | -8.35 Mn |
| Sep 30, 2024 | -9.10 Mn |
| Sep 30, 2024 | -9.10 Mn |
| Jun 30, 2024 | -10.58 Mn |
| Jun 30, 2024 | -10.58 Mn |
| Mar 31, 2024 | -14.56 Mn |
| Mar 31, 2024 | -14.56 Mn |